Company: Quell Therapeutics
Location: London
Posted: April 25th, 2026
At Quell we seek to deliver truly innovative, life‑changing therapies for our patients. Our vision is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.
Quell was founded in March 2019 in partnership with six prominent immunological experts from King's College London, University College London, and Hannover Medical School, and is led by Iain McGill, a leading pharmaceutical executive with extensive relevant experience, having spent most of his 25 years in the industry in immunology, including the areas of solid organ and cell transplantation. The company was founded with an initial Series A financing, led by Syncona Ltd who committed $83 M with a further $1 M contributed by UCL Technology Fund.
Quell is looking for a qualified (up to 5 years PQE) UK and European in‑house patent attorney with a strong background in cell and protein engineering, immunology and immunotherapy.
The role is part‑time (2.5–3 days/week) and has a fixed‑term of 10 months for maternity leave cover, with an anticipated start in July/Aug 2026. Reporting directly to the VP, IP, you will be highly motivated, organised and personable, with good communication skills.
The ideal candidate will have experience working with direct clients or in‑house and must be capable of working as part of a team, directly with scientists.